Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | References | |
Homo sapiens | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | References | |
Homo sapiens | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | 1068 aa | 927 aa | 29.0 % |
Trypanosoma brucei | phosphatidylinositol 4-kinase alpha, putative | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | 582 aa | 491 aa | 25.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | bifunctional protein NCOAT | 0.8236 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0509 | 0.0476 | 0.7549 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0923 | 0.0986 | 0.0904 |
Schistosoma mansoni | aminopeptidase P homologue (M24 family) | 0.8236 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.3499 | 0.4161 | 0.4123 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0197 | 0.0091 | 0.5 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0611 | 0.0601 | 1 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0923 | 0.0986 | 0.0724 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0611 | 0.0601 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0251 | 0.0158 | 0.1307 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0822 | 0.0861 | 0.0802 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0611 | 0.0601 | 0.0515 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0589 | 0.0574 | 0.9475 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase vps34-like | 0.0197 | 0.0091 | 0.0498 |
Schistosoma mansoni | Hyaluronidase | 0.8236 | 1 | 1 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0611 | 0.0601 | 1 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0923 | 0.0986 | 0.0724 |
Loa Loa (eye worm) | hypothetical protein | 0.0353 | 0.0283 | 0.022 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0312 | 0.0233 | 0.0144 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0611 | 0.0601 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0611 | 0.0601 | 1 |
Giardia lamblia | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.0354 | 0.0284 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0509 | 0.0476 | 0.7549 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0611 | 0.0601 | 1 |
Echinococcus multilocularis | bifunctional protein NCOAT | 0.8236 | 1 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0353 | 0.0283 | 0.0193 |
Loa Loa (eye worm) | hyaluronidase | 0.8236 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0258 | 0.0167 | 0.0103 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0455 | 0.0409 | 0.6242 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0455 | 0.0409 | 0.6242 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity | Toxicity in Harlan nude mouse xenografted with Rat1 cells expressing myr-p110alpha assessed as change in body weight at 25 to 50 mg/kg, po qd administered for 8 days measured during compound dosing | LITERATURE. | 27575470 | |
Activity | Toxicity in Harlan nude mouse xenografted with Rat1 cells expressing myr-p110alpha assessed as change in body weight at 100 mg/kg, po administered every second day from day 2 onwards for 8 days measured during compound dosing | LITERATURE. | 27575470 | |
Activity | = 11 % | Toxicity in Harlan nude mouse xenografted with Rat1 cells expressing myr-p110alpha assessed as reduction in body weight at 100 mg/kg, po qd administered for 8 days measured on day 4 | LITERATURE. | 27575470 |
IC50 (binding) | = 0.022 uM | Inhibition of PI3Kalpha (unknown origin) using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay | LITERATURE. | 27575470 |
IC50 (binding) | = 0.039 uM | Inhibition of PI3Kalpha (unknown origin) expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser473 residue | LITERATURE. | 27575470 |
IC50 (binding) | = 1.53 uM | Inhibition of PI3Kdelta (unknown origin) expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser473 residue | LITERATURE. | 27575470 |
IC50 (binding) | = 2.07 uM | Inhibition of PI3Kbeta (unknown origin) using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay | LITERATURE. | 27575470 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.